SHS has sold Spiegelberg to Luciole Medical AG
May 2023 — SHS and a minority co-shareholder have sold Spiegelberg GmbH to Luciole Medical AG.
Spiegelberg is a manufacturer of neuromonitoring and neurosurgical medical products. The company is known for its unique self-calibrating intra-cranial pressure monitors and its solid probes. The portfolio further includes disposables such as cerebrospinal fluid management catheters. The company was established more than 30 years ago in Hamburg, Germany, and is active in more than 40 countries.
Luciole Medical has established a first-mover position in brain monitoring by providing a complete solution to measure brain function parameters in a broad range of hospital settings, from surgeries and anesthesia to neurocritical care. Luciole Medical’s adhesive patch, intracranial probe and end-to-end analytics platform that can integrate information from additional sources, provide an array of tools to achieve unparalleled real-time data capture of cerebral oxygenation, an important predictor of brain function. It is the only company with a patch and a patented technology that can also measure the blood flow in the brain.
Since its foundation in 1993, SHS has been investing in innovative companies in the healthcare sector. With its investments, the firm helps shape European champions in their respective healthcare segments or support them in their further expansion. In addition to capital, SHS essentially supports its networks and expertise in the areas of approval and reimbursement in the USA and China, marketing and sales, staffing and exit planning.
Our role in the transaction
Oaklins’ team in Germany acted as the exclusive sell-side M&A advisor in this transaction.
Talk to the deal team
Related deals
Comtax has been acquired by Ryan
Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.
Learn moreCibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn more